Haemonetics Corp. (HAE) Tops Q3 EPS by 7c; Narrows FY11 EPS Outlook

January 31, 2011 8:23 AM

Haemonetics Corp. (NYSE: HAE) reported Q3 EPS of $0.89, $0.07 better than the analyst estimate of $0.82 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found